Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R McCurdy

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
European Journal of Pharmacology|January 2, 2014
Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitroNidhi Kaushal, Matthew J Robson, Abagail Rosen, et al.
Addiction Biology|June 28, 2018
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynineScott E Hemby, Scot McIntosh, Francisco Leon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 13, 2012
Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic studySeshulatha Jamalapuram, Pradeep K Vuppala, Christophe Mesangeau, et al.
Frontiers in Pharmacology|April 4, 2022
Editorial: The Pharmacology of Kratom and Its AlkaloidsOliver Grundmann, Christopher R McCurdy, Darshan Singh, et al.
Addiction (Abingdon, England)|December 4, 2024
The rise of novel, semi-synthetic 7-hydroxymitragnine productsKirsten E Smith, Edward W Boyer, Oliver Grundmann, et al.
Neuropharmacology|August 8, 2007
The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in ratsCatherine B Willmore-Fordham, Daniel M Krall, Christopher R McCurdy, et al.
European Journal of Pharmacology|December 7, 2010
Synthesis and characterization of [³H]-SN56, a novel radioligand for the σ₁ receptorJames A Fishback, Christophe Mesangeau, Jacques H Poupaert, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
Structure activity relationship study of benzo[d]thiazol-2(3H)one based σ receptor ligandsRohit Bhat, James A Fishback, Rae R Matsumoto, et al.
Handbook of Experimental Pharmacology|January 23, 2017
A Role for Sigma Receptors in Stimulant Self-Administration and AddictionJonathan L Katz, Takato Hiranita, Weimin C Hong, et al.
Biomedical Chromatography : BMC|July 30, 2013
Development and validation of a UPLC-MS/MS method for the determination of 7-hydroxymitragynine, a μ-opioid agonist, in rat plasma and its application to a pharmacokinetic studyPradeep K Vuppala, Seshulatha Jamalapuram, Edward B Furr, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|January 2, 2014
Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitroNidhi Kaushal, Matthew J Robson, Abagail Rosen, et al.
Addiction Biology|June 28, 2018
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynineScott E Hemby, Scot McIntosh, Francisco Leon, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 13, 2012
Determination of a highly selective mixed-affinity sigma receptor ligand, in rat plasma by ultra performance liquid chromatography mass spectrometry and its application to a pharmacokinetic studySeshulatha Jamalapuram, Pradeep K Vuppala, Christophe Mesangeau, et al.
Frontiers in Pharmacology|April 4, 2022
Editorial: The Pharmacology of Kratom and Its AlkaloidsOliver Grundmann, Christopher R McCurdy, Darshan Singh, et al.
Addiction (Abingdon, England)|December 4, 2024
The rise of novel, semi-synthetic 7-hydroxymitragnine productsKirsten E Smith, Edward W Boyer, Oliver Grundmann, et al.
Neuropharmacology|August 8, 2007
The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in ratsCatherine B Willmore-Fordham, Daniel M Krall, Christopher R McCurdy, et al.
European Journal of Pharmacology|December 7, 2010
Synthesis and characterization of [³H]-SN56, a novel radioligand for the σ₁ receptorJames A Fishback, Christophe Mesangeau, Jacques H Poupaert, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2013
Structure activity relationship study of benzo[d]thiazol-2(3H)one based σ receptor ligandsRohit Bhat, James A Fishback, Rae R Matsumoto, et al.
Handbook of Experimental Pharmacology|January 23, 2017
A Role for Sigma Receptors in Stimulant Self-Administration and AddictionJonathan L Katz, Takato Hiranita, Weimin C Hong, et al.
Biomedical Chromatography : BMC|July 30, 2013
Development and validation of a UPLC-MS/MS method for the determination of 7-hydroxymitragynine, a μ-opioid agonist, in rat plasma and its application to a pharmacokinetic studyPradeep K Vuppala, Seshulatha Jamalapuram, Edward B Furr, et al.
Pageof 22